HIV/AIDS annually kills millions of people worldwide. Those claimed by the disease are quickly replaced by those newly infected. Three times as many new infections occur globally, as patients who are likely to have access to antiretroviral therapy. We need a HIV vaccine. However, the better HIV protein to target for this vaccine in unknown. Structural proteins such as Group specific antigen (Gag) and Envelope (Env) were thought likely candidates due to viral structural proteins usually being highly conserved and constrained in their ability to mutate to escape T cell attack. To establish if Env-specific T cells could control viraemia, 2 large vaccine trials were conducted with 66 pigtail macaques participating. Also, 2 reversion trials involving 4 pigtail macaques were undertaken. Env-specific T cell epitopes were mapped in both SHIV (simian/human immunodeficiency virus) and SIV (simian immunodeficiency virus)-infected macaques using IFNγ intracellular cytokine staining and flow cytometry.
| Identifer | oai:union.ndltd.org:ADTP/245152 |
| Date | January 2008 |
| Creators | Peut, Vivienne Mary |
| Source Sets | Australiasian Digital Theses Program |
| Language | English |
| Detected Language | English |
| Rights | Terms and Conditions: Copyright in works deposited in the University of Melbourne Eprints Repository (UMER) is retained by the copyright owner. The work may not be altered without permission from the copyright owner. Readers may only, download, print, and save electronic copies of whole works for their own personal non-commercial use. Any use that exceeds these limits requires permission from the copyright owner. Attribution is essential when quoting or paraphrasing from these works., Open Access |
Page generated in 0.0314 seconds